As of January 23, 2024, the latest analyst ratings for Eli Lilly (NYSE: LLY) exhibit a diverse range of sentiments towards the company. Within the current month, there have been 39 Buy Ratings, 6 Hold Ratings, and interestingly, no Sell Ratings. The average 12-month price target stands at $656.33, with a high estimate of $763.00 and a low estimate of $535.00.
Notably, recent actions by analysts have brought forth some noteworthy changes. Carter Gould from Barclays has raised the price target to $680.00, displaying optimism regarding Eli Lilly’s future performance. Eli Lilly of Daiwa Capital has announced an Outperform rating, accompanied by a price target of $610.00. Similarly, Robyn Karnauskas of Truist Securities has maintained a Buy rating and a price target of $650.00.
Comparing the current average price target to the previous one, there has been a slight decrease of 2.4%. The prior average price target was $651.50, indicating a minor adjustment in analysts’ expectations.
Taking into account the overall consensus rating for Eli Lilly, it is classified as a Strong Buy. This conclusion is drawn from a total of 17 buy ratings, 2 hold ratings, and no sell ratings. These ratings collectively suggest a positive outlook for the company’s future prospects.
LLY Stock Analysis: Strong Investor Confidence and Potential for Future Growth
On January 23, 2024, LLY stock exhibited some interesting performances. The stock was trading near the top of its 52-week range, indicating strong investor confidence, and was also above its 200-day simple moving average, which suggests a positive long-term trend.
However, the price of LLY shares experienced a decrease of $7.93 since the market last closed, representing a 1.26% drop. This decline could be attributed to various factors such as market volatility, industry-specific news, or broader economic conditions.
LLY stock opened at $627.50, which was $3.58 lower than its previous close. This lower opening price could have been influenced by overnight news or events that impacted investor sentiment.
Despite the drop in price on January 23, 2024, LLY’s strong performance relative to its 52-week range and its position above the 200-day simple moving average may indicate that the stock has the potential for future growth. However, it is always advisable to consult with a financial advisor or conduct independent research to gain a comprehensive understanding of a stock’s potential before making any investment decisions.
Analyzing Eli Lilly and Companys Stock Performance: Total Revenue, Net Income, and EPS
On January 23, 2024, Eli Lilly and Company’s (LLY) stock performance was influenced by various factors, including its total revenue, net income, and earnings per share (EPS).
Total Revenue:
LLY’s total revenue for the past year stood at $28.54 billion, according to data from CNN Money. Comparing this figure to the total revenue from the previous year, we can observe that it remained flat, indicating that the company maintained a stable revenue stream. However, the total revenue increased by 14.27% since the last quarter, implying a positive growth trend.
Net Income:
The net income of LLY for the past year was $6.24 billion, while in the third quarter, it reported a net loss of -$57.40 million. Comparing these figures, we can observe that the net income increased by 11.88% since the previous year. However, it experienced a significant decline of 103.26% since the last quarter, resulting in a net loss. This decline in net income may have negatively impacted the stock’s performance on January 23, 2024.
Earnings per Share:
LLY’s earnings per share (EPS) for the past year were $6.90, while in the third quarter, it reported an EPS of -$0.06. Comparing these figures, we can observe that the EPS increased by 12.75% since the previous year. However, it experienced a substantial decrease of 103.27% since the last quarter. This decline in EPS may have further contributed to the negative sentiment surrounding the stock’s performance on January 23, 2024.
Overall Analysis:
LLY’s stock performance on January 23, 2024, was influenced by mixed factors. While the total revenue remained stable since the previous year, the significant increase in revenue since the last quarter indicated positive growth. However, the net income and EPS showed contrasting trends. The net income increased since the previous year but experienced a significant decline since the last quarter, resulting in a net loss. Similarly, the EPS increased since the previous year but witnessed a substantial decrease since the last quarter.
Investors and analysts may view the decline in net income and EPS as concerning factors that could have impacted the stock’s performance. However, the positive growth in total revenue since the last quarter may have provided some optimism.
It is important to note that stock performance is influenced by various other factors, including market conditions, industry trends, and company-specific developments. Therefore, it is advisable to consider a comprehensive analysis and consult financial experts before making any investment decisions based solely on these figures.
In conclusion, LLY’s stock performance on January 23, 2024, was influenced by mixed factors, including stable total revenue, a decline in net income, and a decrease in EPS since the last quarter. Investors should carefully analyze these figures along with other relevant information to gain a comprehensive understanding of the stock’s performance and make informed investment decisions.
